Breaking habits: safety and efficacy of elective electrocardioversion of atrial fibrillation and atrial flutter in the setting of day hospital
- Ammar Brkić
(University Clinical Centre Tuzla, Tuzla, Internal Medicine Clinic, Bosnia and Herzegovina)
- Minela Bećirović (University Clinical Centre Tuzla, Tuzla, Internal Medicine Clinic, Bosnia and Herzegovina)
- Emir Bećirović (University Clinical Centre Tuzla, Tuzla, Internal Medicine Clinic, Bosnia and Herzegovina)
- Tarik Brkić (University Clinical Centre Tuzla, Tuzla, Clinic of Invasive Cardiology, Bosnia and Herzegovina)
- Esad Brkić (University Clinical Centre Tuzla, Tuzla, Internal Medicine Clinic, Bosnia and Herzegovina)
- Denis Mršić (University Clinical Centre Tuzla, Tuzla, Internal Medicine Clinic, Bosnia and Herzegovina)
- Amir Bećirović (University of Tuzla, Tuzla, School of Medicine, Bosnia and Herzegovina)
- Amila Jašarević (University Clinical Centre Tuzla, Tuzla, Internal Medicine Clinic, Bosnia and Herzegovina)
- Emir Softić (Cantonal Hospital Zenica, Zenica, Department of Emergency Medicine, Bosnia and Herzegovina)
- Alma Mujić Ibralić (Health centre Živinice, Živinice, Bosnia and Herzegovina)
Abstract
Aim: To examine safety and efficiency of electrocardioversion (EC) in elective treatment of atrial fibrillation and atrial flutter in the setting of Day Hospital by determining success rate, frequency of adverse events and possible cost benefit compared to admitting a patient into hospital.
Methods: This prospective observational cohort study was performed in Day Hospital and in Intensive Care Department of Internal Medicine Clinic, University Clinical Centre Tuzla from January 2019 to December 2022 and included 98 patients with a persistent form of atrial fibrillation (AF) or atrial flutter. The patients who were divided in two groups, 56 hospitalized and 42 patients accessed in Day Hospital. In all patients, medical history, physical examination, electrocardiogram (ECG) and transthoracic echocardiogram (TTE) evaluation was performed in addition to laboratory findings. Electrocardioversion was performed with a monophasic General Electric defibrillator in anterolateral electrode position with up to three repetitive shocks.
Results: In hospital setting group overall succes rate of electrocardioversion was 85%, with average 2.1 EC attemps, there was with one fatal outcome due to stroke, one case of ventricular fibrillation (VF) due to human error, and 6 minor adverse events; with average cost of was 1408.70 KM (720.23 €) per patient. In Day Hospital setting succes rate was 88%, with average 2 EC attempts, no major adverse events, 8 minor adverse events; and average cost was of 127.23 KM (65.05 €) per patient.
Conclusion: Performing elective electrocardioversion in Day Hospital setting is as safe as admitting patients into hospital but substantially more cost effective.
Keywords: adverse events, cost benefit analysis, electrocardiography, intensive care unit
How to Cite:
Brkić, A., Bećirović, M., Bećirović, E., Brkić, T., Brkić, E., Mršić, D., Bećirović, A., Jašarević, A., Softić, E. & Mujić Ibralić, A., (2023) “Breaking habits: safety and efficacy of elective electrocardioversion of atrial fibrillation and atrial flutter in the setting of day hospital”, Medicinski glasnik 21(1), 23-28. doi: https://doi.org/10.17392/1640-23
Downloads:
Download PDF
View PDF
0 Views
0 Downloads